{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:03:46Z","timestamp":1794877426634,"version":"4.9.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>\n                           <jats:italic toggle=\"yes\">Anaplastic lymphoma kinase<\/jats:italic> (<jats:italic toggle=\"yes\">ALK<\/jats:italic>) rearrangements drive most examples of epithelioid fibrous histiocytoma (EFH) and have been reported in an emerging family of receptor tyrosine kinase (RTK) fusion-positive mesenchymal neoplasms, including superficial ones described under the rubric of \u201csuperficial <jats:italic toggle=\"yes\">ALK<\/jats:italic>-rearranged myxoid spindle cell neoplasm\u201d (SAMS). Here, we describe 35 superficial tumors with SAMS morphology, which occurred in 18 females (51%) and 17 males at a median age at presentation of 39 years (range: 6 to 82\u00a0y). Most tumors occurred on the lower extremity (25 tumors; 71%), followed by upper extremity (5; 14%), trunk (3; 9%), and face (2; 6%). Nine tumors were reported to have grown slowly before presentation, including &gt;10 years in 2 cases. Tumors occurred primarily in the dermis (32 tumors; 91%) or subcutis (3; 9%); 8 dermal tumors extended into the subcutis. Median tumor size was 1.3\u00a0cm (range: 0.5 to 8.0\u00a0cm). Clinical follow-up was available for 12 patients (34%; range: 2\u00a0mo to 21\u00a0y; median: 2.7\u00a0y), none of whom experienced metastasis. One incompletely resected tumor recurred locally at 19 months, and no other patients experienced recurrence. Histologically, tumors were characterized by bland spindle-to-ovoid cells showing whorled growth and myxoid-to-collagenous stroma. Recurrent features included an epidermal collarette (19\/30; 63%), perivascular hyalinization (20\/35; 57%), amianthoid collagen (14\/35; 40%), and metaplastic ossification (2\/35; 6%). Immunohistochemistry (IHC) demonstrated expression of ALK (24\/31; 77%), CD34 (15\/21; 71%), EMA (17\/28; 61%), and S-100 (9\/32; 28%). Eleven tumors showed hybrid morphologic features between EFH and SAMS; 9 of them (82%) showed cytomorphology typical of EFH but with whorled growth, myxoid stroma, and\/or regions of spindle cell morphology. Two hybrid tumors showed sharp transitions between a region characteristic of EFH and a region characteristic of SAMS, with a concomitant sharp transition in EMA, CD34, and S-100 expression by IHC. Sequencing revealed <jats:italic toggle=\"yes\">ALK<\/jats:italic> fusions in 15 of 19 tumors: 2 each with fusion partners <jats:italic toggle=\"yes\">FLNA<\/jats:italic>, <jats:italic toggle=\"yes\">SQSTM1<\/jats:italic>, and <jats:italic toggle=\"yes\">VCL<\/jats:italic>, and 1 each with <jats:italic toggle=\"yes\">COL1A2, DCTN1, EML4, FXR1, MPRIP<\/jats:italic>, <jats:italic toggle=\"yes\">PLEKHH2, PRKAR1A, SPECC1L<\/jats:italic>, and <jats:italic toggle=\"yes\">TLN2<\/jats:italic>. Thirteen of 14 <jats:italic toggle=\"yes\">ALK<\/jats:italic>-rearranged tumors expressed ALK by IHC. Three tumors negative for <jats:italic toggle=\"yes\">ALK<\/jats:italic> fusions instead harbored alternate RTK fusions (<jats:italic toggle=\"yes\">NCOA4::RET<\/jats:italic>, <jats:italic toggle=\"yes\">TRIM27::RET<\/jats:italic>, and <jats:italic toggle=\"yes\">VIM<\/jats:italic>::<jats:italic toggle=\"yes\">NTRK3<\/jats:italic>), and 1 tumor was negative for RTK alterations. <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic>\/<jats:italic toggle=\"yes\">B<\/jats:italic> deletions were found in 2 tumors with <jats:italic toggle=\"yes\">ALK<\/jats:italic> fusions and both tumors with <jats:italic toggle=\"yes\">RET<\/jats:italic> fusions. SAMS is on a morphologic and molecular genetic spectrum with EFH, with a similar body site distribution, frequent clinical presentation as an exophytic skin tumor, and invariably benign outcomes; we conclude that SAMS should be considered a histologic variant of EFH. Some morphologically typical examples harbor alternate <jats:italic toggle=\"yes\">RET<\/jats:italic> and <jats:italic toggle=\"yes\">NTRK3<\/jats:italic> fusions, such that SAMS is not an appropriate designation for this morphologic class; instead, to highlight the clinicopathologic similarities to EFH, we propose the diagnostic term \u201cmyxoid spindle cell variant of epithelioid fibrous histiocytoma.\u201d<\/jats:p>","DOI":"10.1097\/pas.0000000000002315","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T11:00:23Z","timestamp":1727434823000},"page":"1568-1579","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["Epithelioid Fibrous Histiocytoma Is on a Continuum With Superficial ALK-rearranged Myxoid Spindle Cell Neoplasm"],"prefix":"10.1097","volume":"48","author":[{"given":"Mia S.","family":"DeSimone","sequence":"first","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Odintsov","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison K.","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan C.","family":"Dickson","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed K.","family":"Alomari","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Hornick","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.M.","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7746-3546","authenticated-orcid":false,"given":"David J.","family":"Papke","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/modpathol.2015.49","article-title":"ALK rearrangement and overexpression in epithelioid fibrous histiocytoma","volume":"28","author":"Doyle","year":"2015","journal-title":"Mod Pathol"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2559.1994.tb01290.x","article-title":"Epithelioid benign fibrous histiocytoma of skin: clinico-pathological analysis of 20 cases of a poorly known variant","volume":"24","author":"Gomez","year":"1994","journal-title":"Histopathology"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2133.1989.tb07782.x","article-title":"Epithelioid cell histiocytoma: a new entity","volume":"120","author":"Jones","year":"1989","journal-title":"Br J Dermatol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/modpathol.2017.191","article-title":"Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases","volume":"31","author":"Dickson","year":"2018","journal-title":"Mod Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/bjd.13548","article-title":"Epithelioid cell histiocytoma of the skin with clonal ALK gene rearrangement resulting in VCL-ALK and SQSTM1-ALK gene fusions","volume":"172","author":"Jedrych","year":"2015","journal-title":"Br J Dermatol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/DAD.0000000000001085","article-title":"ALK gene fusions in epithelioid fibrous histiocytoma: A study of 14 cases, with new histopathological findings","volume":"40","author":"Kazakov","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/gcc.23038","article-title":"Molecular investigation of ALK-rearranged epithelioid fibrous histiocytomas identifies CLTC as a novel fusion partner and evidence of fusion-independent transcription activation","volume":"61","author":"Georgantzoglou","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13000-018-0704-1","article-title":"Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report","volume":"13","author":"Nakayama","year":"2018","journal-title":"Diagn Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/s41379-021-00830-w","article-title":"Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile","volume":"34","author":"Dermawan","year":"2021","journal-title":"Mod Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/cup.13923","article-title":"Spindle cell variant of epithelioid cell histiocytoma (spindle cell histiocytoma) with ALK gene fusions: cases series and review of the literature","volume":"48","author":"Kazlouskaya","year":"2021","journal-title":"J Cutan Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/PAI.0000000000000418","article-title":"ALK rearrangement and overexpression in an unusual cutaneous epithelioid tumor with a peculiar whorled \u201cperineurioma-like\u201d growth pattern: epithelioid fibrous histiocytoma","volume":"25","author":"Creytens","year":"2017","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2559.2001.1232c.x","article-title":"Prominent cellular whorls within an epithelioid histiocytoma","volume":"39","author":"Cook","year":"2001","journal-title":"Histopathology"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1600-0560.2011.01747.x","article-title":"EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall","volume":"38","author":"Doyle","year":"2011","journal-title":"J Cutan Pathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of OncoPanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/bioinformatics\/btv710","article-title":"Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications","volume":"32","author":"Chen","year":"2016","journal-title":"Bioinformatics"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv1234","article-title":"Comprehensive evaluation of fusion transcript detection algorithms and a meta-caller to combine top performing methods in paired-end RNA-seq data","volume":"44","author":"Liu","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/gcc.23097","article-title":"ALK-rearranged mesenchymal neoplasms: a report of 9 cases further expanding the clinicopathologic spectrum of emerging kinase fusion positive group of tumors","volume":"62","author":"Dermawan","year":"2023","journal-title":"Genes Chromosomes Cancer"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"100334","DOI":"10.1016\/j.modpat.2023.100334","article-title":"ALK-rearranged epithelioid mesenchymal neoplasm: expanding the spectrum of tyrosine kinase-altered mesenchymal tumors","volume":"36","author":"Gestrich","year":"2023","journal-title":"Mod Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41379-021-00952-1","article-title":"Superficial ALK-rearranged myxoid spindle cell neoplasm with a novel FMR1-ALK fusion gene","volume":"35","author":"Kao","year":"2022","journal-title":"Mod Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/cup.14354","article-title":"A novel case of cutaneous myxoid spindle cell neoplasm with FMR1-ALK gene fusion and CD34\/S100 co-expression","volume":"50","author":"Kasago","year":"2023","journal-title":"J Cutan Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"jcp-2024-209521","DOI":"10.1136\/jcp-2024-209521","article-title":"ALK-rearranged mesenchymal neoplasms: a clinicopathological and molecular study of eight additional cases of an emerging group of tyrosine kinase fusion mesenchymal tumours","author":"Zhao","year":"2024","journal-title":"J Clin Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/gcc.22844","article-title":"Novel PPP1CB-ALK fusion in spindle cell tumor defined by S100 and CD34 coexpression and distinctive stromal and perivascular hyalinization","volume":"59","author":"Lopez-Nunez","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/cup.13926","article-title":"Spindle cell tumor with CD34 and S100 co-expression and distinctive stromal and perivascular hyalinization showing EML4-ALK fusion","volume":"48","author":"Abs","year":"2021","journal-title":"J Cutan Pathol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/gcc.22917","article-title":"Spindle cell neoplasm with EML4-ALK gene fusion presenting as an intraosseous vertebral mass","volume":"60","author":"Mantilla","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"151800","DOI":"10.1016\/j.anndiagpath.2021.151800","article-title":"Novel fusion sarcomas including targetable NTRK and ALK","volume":"54","author":"Chen","year":"2021","journal-title":"Ann Diagn Pathol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/10668969221080072","article-title":"Pediatric non-myofibroblastic primitive spindle cell tumors with ALK gene rearrangements and response to crizotinib","volume":"30","author":"Rakheja","year":"2022","journal-title":"Int J Surg Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/PAS.0000000000001925","article-title":"Gastroesophageal glomus tumors: clinicopathologic and molecular genetic analysis of 26 cases with a proposal for malignancy criteria","volume":"46","author":"Papke","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13569-019-0112-7","article-title":"Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs)","volume":"9","author":"Heinrich","year":"2019","journal-title":"Clin Sarcoma Res"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/path.6260","article-title":"Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with NTRK and other kinase gene aberrations","volume":"263","author":"Klub\u00ed\u010dkov\u00e1","year":"2024","journal-title":"J Pathol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/DAD.0b013e31816f150a","article-title":"Cutaneous lipomatous sclerosing perineurioma","volume":"30","author":"Macarenco","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00000372-200304000-00018","article-title":"Perineurioma with adipocytes (lipomatous perineurioma)","volume":"25","author":"Zamecnik","year":"2003","journal-title":"Am J Dermatopathol"},{"key":"R32-20250608","first-page":"366","article-title":"Perineurioma with ossification: a case report with immunohistochemical and ultrastructural studies","volume":"122","author":"Rank","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.pas.0000155166.86409.d2","article-title":"Soft tissue perineurioma: clinicopathologic analysis of 81 cases including those with atypical histologic features","volume":"29","author":"Hornick","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.humpath.2003.08.016","article-title":"Cutaneous myoepithelioma: a clinicopathologic and immunohistochemical study of 14 cases","volume":"35","author":"Hornick","year":"2004","journal-title":"Hum Pathol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/PAS.0b013e3182772bba","article-title":"Cutaneous syncytial myoepithelioma: clinicopathologic characterization in a series of 38 cases","volume":"37","author":"Jo","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/PAS.0000000000000398","article-title":"Sox10\u2014a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors","volume":"39","author":"Miettinen","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1111\/1346-8138.15943","article-title":"Benign cutaneous plexiform hybrid tumor of perineurioma and cellular neurothekeoma on the leg","volume":"48","author":"Sakaguchi","year":"2021","journal-title":"J Dermatol"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ad.2016.03.002","article-title":"Benign cutaneous plexiform hybrid tumor of perineurioma and cellular neurothekeoma","volume":"107","author":"Are\u00e1n","year":"2016","journal-title":"Actas Dermosifiliogr"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/DAD.0000000000000105","article-title":"Benign cutaneous biphasic hybrid tumor of perineurioma and cellular neurothekeoma: a case report expanding the clinical and histopathologic features of a recently described entity","volume":"37","author":"Linos","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1746-1596-8-165","article-title":"Benign cutaneous plexiform hybrid tumor of perineurioma and cellular neurothekeoma arising from the nose","volume":"8","author":"Yamada","year":"2013","journal-title":"Diagn Pathol"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/PAS.0b013e31827edfda","article-title":"A benign cutaneous plexiform hybrid tumor of perineurioma and cellular neurothekeoma","volume":"37","author":"Requena","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/01.pas.0000173025.87476.a4","article-title":"Nerve sheath myxoma: a clinicopathologic and immunohistochemical analysis of 57 morphologically distinctive, S-100 protein- and GFAP-positive, myxoid peripheral nerve sheath tumors with a predilection for the extremities and a high local recurrence rate","volume":"29","author":"Fetsch","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2559.2009.03447.x","article-title":"Cutaneous fibrohistiocytic tumours\u2014an update","volume":"56","author":"Luzar","year":"2010","journal-title":"Histopathology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T20:01:24Z","timestamp":1749412884000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002315"}},"subtitle":["A Clinicopathologic Series of 35 Cases Including Alternate RET and NTRK3 Fusions"],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002315","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]}}}